Degradation of IRAK4 for the treatment of lipopolysaccharide-induced acute lung injury in mice
Bo Ye(University of Minnesota), Lulu Zheng(Zhejiang Provincial People's Hospital)
Cited by 1
Related Papers
Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory Diseases
|Journal of Medicinal Chemistry|2024|6
Calcifying fibrous tumor of stomach: a rare case report of an upper gastrointestinal bleeding
|Frontiers in Oncology|2025|0